Abraham, Pranav <br/><br/>
Real-world treatment patterns, cost of care and effectiveness of therapies for patients with squamous cell carcinoma of head and neck pre and post approval of immuno-oncology agents.  [electronic resource] 

 -  Journal of medical economics  Feb 2020 
 - 125-131 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1941-837X 
<br/><br/><label>Standard No.: </label>10.1080/13696998.2019.1676760  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--economics<br/>Female<br/>Head and Neck Neoplasms--drug therapy<br/>Health Expenditures--statistics & numerical data<br/>Health Resources--economics<br/>Health Services--economics<br/>Humans<br/>Insurance Claim Review<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neoplasm Recurrence, Local<br/>Nivolumab--administration & dosage<br/>Patient Acceptance of Health Care<br/>Retrospective Studies<br/>Squamous Cell Carcinoma of Head and Neck--drug therapy